Epilepsy is a disabling disease characterized by a wide variety of underlying pathologies, resulting in the common, crucial denominator of this illness, seizures. Even though numerous anti-seizure medications are available, one-third of patients still experience pharmaco-resistant epilepsy [1]. For these patients, surgery remains the final recourse. Yet, despite the promising prospects of seizure freedom in up to 64 % of the cases [2], resective surgery often remains an underutilized tool with s…